Evidence map›Paper›PMID 39852275›Full record

ArticleMembranes2025

Evaluation of Ceramic Membrane Filtration for Alternatives to Microplastics in Cosmetic Formulations Using FlowCam Analysis.

Seung Yeon Kim, Soyoun Kim, Chanhyuk Park

Abstract read
In one paragraph

Article in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Seung Yeon KimDepartment of Environmental Science and Engineering, Ewha Womans University, Seoul 03760, Republic of Korea.
Soyoun KimDepartment of Environmental Science and Engineering, Ewha Womans University, Seoul 03760, Republic of Korea.
Chanhyuk ParkDepartment of Environmental Science and Engineering, Ewha Womans University, Seoul 03760, Republic of Korea.ORCID 0000-0002-9789-2388

Funding

National Research Foundation of Korea No. 2021R1C1C1006444Seoul Green Environment Center None
6 · The paper itself

Abstract

The rapid expansion of the cosmetics industry has significantly increased the adoption of alternative microplastics in response to increasingly stringent global environmental regulations. This study presents a comparative analysis of the treatment performance of silica powder and cornstarch-common alternatives for microplastics in cosmetics-using ceramic membrane filtration combined with flow imaging microscopy (FlowCam) to analyze particle behavior. Bench-scale crossflow filtration experiments were performed with commercially available alumina ceramic membranes. By analyzing high-resolution images from FlowCam, the transport and retention behaviors of the two microplastic alternatives were examined by comparing their morphological properties. Despite their similar particle sizes, the cornstarch demonstrated a higher removal efficiency (82%) than the silica (72%) in the ceramic membrane filtration due to its greater tendency to aggregate. This increased tendency for aggregation suggests that cornstarch may contribute to faster fouling, while the stability and uniformity of silica particles result in less fouling. The FlowCam analysis revealed that the cornstarch particles experienced a slight increase in circularity and compactness over time, likely due to physical swelling and aggregation, while the silica particles retained their shape and structural integrity. These findings highlight the impact of the morphological properties of alternative microplastics on their filtration behavior and fouling potential.

Indexed as

alternative microplasticsceramic membranecornstarchfluid imaging microscopysilica particle

Identifiers

PMID39852275
PMCPMC11767035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.